질 슬링 시장 : 제품 유형별, 요실금 유형별, 유형별, 최종 용도별 - 세계 예측(2024-2032년)

Global Vaginal Slings Market will expand at a 9% CAGR from 2024 to 2032, attributed to increasing awareness of treatment options coupled with advancements in surgical techniques and materials. As patients become more informed about minimally invasive procedures and their benefits, demand for effective solutions for pelvic floor disorders rises. Moreover, continuous innovation in sling design and materials enhances patient outcomes and satisfaction. With healthcare providers increasingly adopting these techniques and patients seeking improved quality of life, the vaginal slings industry will expand significantly.

For instance, in October 2022, Urolon, an innovative therapy for female stress urinary incontinence, debuted in the UK. This minimally invasive treatment with a duration of approximately 20 minutes is suitable for administration in either a hospital or clinic setting. The launch expands the range of treatment options available for female stress urinary incontinence, contributing to the diversification and growth of the market.

The vaginal slings industry is classified based on product, incontinence type, and region.

The tension-free vaginal tape segment will capture noteworthy market share through 2032, propelled by its efficacy in treating stress urinary incontinence and pelvic organ prolapse. With minimal invasiveness and high success rates, tension-free vaginal tape procedures offer patients effective and long-lasting solutions. Moreover, technological advancements have improved tape design and materials, enhancing patient outcomes. As healthcare providers increasingly adopt this method and patients seek minimally invasive treatment options, the tension-free vaginal tape segment will secure the largest share in the vaginal slings industry.

The vaginal slings market share from the mixed incontinence segment will experience a substantial upswing by 2032 due to its versatile treatment approach addressing both stress and urge urinary incontinence. With a significant patient population experiencing mixed symptoms, the demand for effective and comprehensive solutions is high. Technological advancements in sling design cater specifically to mixed incontinence, offering patients an improved quality of life. As healthcare providers prioritize tailored treatment options and patients seek comprehensive care, the mixed incontinence segment will stand as a prominent player in the vaginal slings market outlook.

Asia Pacific vaginal slings industry will record a remarkable CAGR by 2032, fueled by factors such as increasing awareness of urinary incontinence treatments, a rising geriatric population, and improving healthcare infrastructure. Moreover, the region's large population base and growing disposable income contribute to market growth. Technological advancements and favorable government initiatives will further propel the adoption of vaginal sling procedures in the region. With these factors combined, Asia Pacific will emerge as the pivotal contributor to the vaginal slings industry.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Base estimates & workings
• 1.5 Forecast calculations
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of urinary incontinence (UI)
    • 3.2.1.2 Growing geriatric population
    • 3.2.1.3 Increasing advancements in surgical techniques
    • 3.2.1.4 Rising awareness of pelvic floor disorders and their treatment options
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of vaginal sling procedure
    • 3.2.2.2 Safety and efficacy concerns
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis
• 3.8 Reimbursement scenario
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Transobturator slings
• 5.3 Tension-free vaginal tape slings
• 5.4 Mini-slings

Chapter 6 Market Estimates and Forecast, By Incontinence Type, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Stress incontinence
• 6.3 Urge incontinence
• 6.4 Mixed incontinence

Chapter 7 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Midurethral sling
• 7.3 Traditional sling

Chapter 8 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 A.M.I. GmbH
• 10.2 B. Braun Melsungen AG
• 10.3 Betatech Medical
• 10.4 Boston Scientific Corporation
• 10.5 Caldera Medical
• 10.6 Coloplast Corp
• 10.7 Cousin Surgery
• 10.8 Johnson & Johnson Services, Inc.
• 10.9 Lotus Surgicals
• 10.10 Neomedic International
• 10.11 Promedon S.A.
• 10.12 UroCure